Comparative study of photodegradation of three hematoporphyrin derivative:: Photofrin®, Photogem® and Photosan

被引:30
作者
Ferreira, J.
Menezes, P. F. C. [1 ]
Kurachi, C.
Sibata, C. H.
Allison, R. R.
Bagnato, V. S.
机构
[1] Univ Sao Paulo, Inst Fis Sao Carlos, BR-13566590 Sao Carlos, SP, Brazil
[2] E Carolina Univ, Brody Sch Med, Leo Jenkins Canc Ctr, Dept Radiat Oncol, Greenville, NC USA
关键词
photodynamic therapy; porphyrins; photosensitizer; phototransformation rate; LED;
D O I
10.1002/lapl.200710058
中图分类号
O43 [光学];
学科分类号
070207 ; 0803 ;
摘要
We report the photodegradation of the three different photosensitizers derived from hematoporphyrin. In this paper we use the term phototransformation for describing the photodegradation or photobleaching process. This photodegradation alters the fluorescence during illumination. The rate of fluorescence variation was normalized to the solution absorption and the photon energy, resulting in the determination of the necessary number of photons to be absorbed to induce photosensitizer phototransformation. The parameter for rate of the molecules decay, the photon fluence rate and optical properties of the solution, allow us to determine the photosensitizer stability in solution during illumination. The results show that the order of susceptibility for phototransformation rate is: Photofrin (R) congruent to Photogem (R) < Photosan (R) This difference in the phototransformation rate for Photosan(D can be explained by the high proportion of aggregates in solution that inhibit the photo-oxidative process that impede the singlet oxygen formation. We hypothesize that there is a con-elation between phototransformation rate and photodynamic efficacy witch is governed by singlet oxygen formation responsible by most relevant reaction for the photodynamic induction of cell death.
引用
收藏
页码:743 / 748
页数:6
相关论文
共 40 条
[1]  
ALLISON RR, 2006, FUTURE ONCOL, V1, P53
[2]   Photodynamic therapy of pigmented melanoma B16 using sterically stabilized fullerenosomes [J].
Babincová, M ;
Sourivong, P ;
Leszczynska, D ;
Babinec, P .
LASER PHYSICS LETTERS, 2004, 1 (09) :476-478
[3]  
Bagdonas S, 2000, PHOTOCHEM PHOTOBIOL, V72, P186, DOI 10.1562/0031-8655(2000)072<0186:POAAIP>2.0.CO
[4]  
2
[5]   Spectroscopic and biological testing of photobleaching of porphyrins in solutions [J].
Bezdetnaya, L ;
Zeghari, N ;
Belitchenko, I ;
BarberiHeyob, M ;
Merlin, JL ;
Potapenko, A ;
Guillemin, F .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1996, 64 (02) :382-386
[6]   Photobleaching of compounds of the 5,10,15,20-tetrakis(m-hydroxyphenyl)-porphyrin series (m-THPP, m-THPC, and m-THPBC) [J].
Bonnett, R ;
Martínez, G .
ORGANIC LETTERS, 2002, 4 (12) :2013-2016
[7]   Photobleaching of sensitisers used in photodynamic therapy [J].
Bonnett, R ;
Martínez, G .
TETRAHEDRON, 2001, 57 (47) :9513-9547
[8]   The present and future role of photodynamic therapy in cancer treatment [J].
Brown, SB ;
Brown, EA ;
Walker, I .
LANCET ONCOLOGY, 2004, 5 (08) :497-508
[9]   THE COMPOSITION OF PHOTOFRIN-II [J].
BYRNE, CJ ;
MARSHALLSAY, LV ;
WARD, AD .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 1990, 6 (1-2) :13-27
[10]   MECHANISMS FOR THE PHOTO-OXIDATION OF PROTOPORPHYRIN-IX IN SOLUTION [J].
COX, GS ;
WHITTEN, DG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1982, 104 (02) :516-521